CLSDQ — Clearside Biomedical, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1539029 ·
Last close
$0.31
Market Cap
$1.65M
52W High
$0.85
52W Low
$0.04
ADV30
15,443
Next earnings
2026-05-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 201,000 | 201,000 | -7,040,000 | -5,972,000 | 11,641,000 | 6,801,000 | 65,591,000 |
| Jun 2025 | 492,000 | 492,000 | -3,568,000 | -4,495,000 | 15,332,000 | 9,376,000 | 64,066,000 |
| Mar 2025 | 2,330,000 | 2,082,000 | -5,205,000 | -8,223,000 | 19,668,000 | 13,628,000 | 65,578,000 |
| Dec 2024 | 306,000 | 157,000 | -7,149,000 | -7,306,000 | 25,126,000 | 20,020,000 | 63,981,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-21,293,000
Investing CF
$9,298,000
Financing CF
$4,908,000
CapEx
$-506,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.19
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-373,965,000
Inventory
—
Receivables
$266,000
ST Investments
$9,703,000
EBIT TTM
$-14,697,000
Pretax Income TTM
$-25,281,000
Interest Exp TTM
$10,584,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,329,000
EBITDA
$-22,630,000
Free Cash Flow
$-20,525,250
Enterprise Value
$56,461,228
Total Cash
$6,801,000
Total Debt
$61,613,000
Shares Out
5,233,981
Trailing EPS
$-5.11
Book Value
$-10.31
ROE
—
ROA
-70.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 1,664,000 | -28,882,000 | -34,352,000 | 25,126,000 | 63,981,000 | — | -24,698,000 |
| Dec 2023 | 8,226,000 | -24,844,000 | -32,485,000 | 34,018,000 | 49,930,000 | — | -18,135,000 |
| Dec 2022 | 1,327,000 | -30,277,000 | -32,947,000 | 51,303,000 | 40,696,000 | — | -13,365,000 |
| Dec 2021 | 29,575,000 | -627,000 | 376,000 | 42,903,000 | 4,928,000 | — | -10,733,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-4.80
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UPC | Universe Pharmaceuticals INC | $1.65M | $2.61 | — |
| PCYN | PROCYON CORP | $1.64M | $0.20 | — |
| JAGX | Jaguar Health, Inc. | $1.60M | $3.11 | — |
| AXIM | AXIM BIOTECHNOLOGIES, INC. | $1.80M | $0.01 | — |
| ZVSA | ZyVersa Therapeutics, Inc. | $1.46M | $0.18 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.